Defensive and adverse energy-related molecular responses precede tris (1, 3-dichloro-2-propyl) phosphate cytotoxicity

Jinkang Zhang1, Timothy D Williams1, James K Chipman1

  • 1School of Biosciences, University of Birmingham, Birmingham, B15 2TT, UK.

Insights

Tris (1, 3-dichloro-2-propyl) phosphate (TDCIPP) exposure triggers cellular defense and energy metabolism changes in human cells. These molecular responses precede observable cytotoxic effects, revealing early toxicity mechanisms.

Area of Science:

  • Environmental Toxicology
  • Molecular Biology
  • Cellular Response to Chemicals

Background:

  • Tris (1, 3-dichloro-2-propyl) phosphate (TDCIPP) is a flame retardant with potential human health risks.
  • Understanding the molecular mechanisms of TDCIPP toxicity is crucial for risk assessment.

Purpose of the Study:

  • To investigate the molecular responses of human cells to TDCIPP exposure.
  • To elucidate the early cellular defense and metabolic alterations induced by TDCIPP.

Main Methods:

  • Combined transcriptomic and metabolomic analyses were performed on HepG2/C3A and A549 cells.
  • Cells were exposed to varying concentrations of TDCIPP (1, 10, 100 μM) for 24 and 72 hours.

Main Results:

  • Transcriptional stress responses, including xenobiotic metabolism and ABC transporter pathways, were observed at 10 μM TDCIPP.
  • At 100 μM TDCIPP, oxidative phosphorylation was downregulated, alongside suppressed cell proliferation pathways.
  • Functional metabolic shifts in HepG2/C3A cells at 72 hours correlated with 24-hour transcriptional changes.

Conclusions:

  • Cellular defense mechanisms and energy metabolism alterations occur before significant cytotoxicity from TDCIPP.
  • These findings provide insights into the early molecular events following TDCIPP exposure in human cells.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.9K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
114
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
176
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
149
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
217
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K